Human papillomavirus anogenital disease in HIV-infected individuals

Dermatologic Therapy

Volumn 18, Issue 1, 2005, Pages 67-76

  Chin Hong, Peter V ^a,b   Palefsky, Joel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV infection; Human papillomavirus; Risk factors; Treatment

Indexed keywords

5 FLUOROTRYPTAMINE; ANTIRETROVIRUS AGENT; CIDOFOVIR; IMIQUIMOD; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; VIRUS VACCINE;

ANUS CANCER; ANUS DISEASE; CANCER SCREENING; COLPOSCOPY; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; GENITAL SYSTEM DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; PAPANICOLAOU TEST; PHYSICAL EXAMINATION; PREVALENCE; REVIEW; SKIN DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ANTIVIRAL AGENTS; ANUS NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS;

EID: 18844414776     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.05009.x     Document Type: Review

References (46)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001: 37 (Suppl. 8): S4-S66.
2. Maiman M, Fruchter RG, Serur E, Boyce JG. Prevalence of human immunodeficiency virus in a colposcopy clinic. JAMA 1988: 260: 2214-2215.
3. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990: 38: 377-382.
4. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000: 92: 1500-1510.
5. Barzegar C, Paul C, Saiag P et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol 1998: 139: 122-127.
6. Palefsky J, Holly E. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995: 4: 415-428.
7. Munoz N, Bosch FX, de San Jose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003: 348: 518-527.
8. Palefsky JM. Anogenital squamous cell cancer and its precursors. In: Goedert JJ, ed. Infectious causes of cancer: targets for intervention. Totawa: NJ Humana Press Inc. 2000: 263-287.
9. Palefsky JM, Minkoff H, Kalish LA et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999: 91: 226-236.
10. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York: Cerv Dis Study. Obstet Gynecol 1994: 84: 591-597.
11. Ellerbrock TV, Chiasson MA, Bush TJ et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000: 283: 1031-1037.
12. Castellsague X, Bosch FX, Munoz N et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002: 346: 1105-1112.
13. Castle PE, Wacholder S, Lorincz AT et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002: 94: 1406-1414.
14. Palefsky JM, Holly E, Ralston MR et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998: 177: 361-367.
15. Palefsky JM. Perspectives: anal cancer in HIV infection. Topics HIV Med 2000: 8: 14-17.
16. Palefsky JM, Holly E, Hogeboom CJ et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J AIDS Hum Retrovirol 1998: 17: 314-319.
17. Cress RD, Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-99. Prev Med 2003: 36: 555-560.
18. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002: 35: 1127-1134.
19. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000: 342: 792-800.
20. Maden C, Sherman KJ, Beckmann AM et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993: 85: 19-24.
21. Marfing TE, Abel M. DM G. Perianal Bowen's disassociated malignancies. Dis Colon Rectum 1987: 30: 782-785.
22. Cleary R, Schaldenbrand J, Fowler J et al. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum 1999: 42: 945-951.
23. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973-87). Am J Obstet Gynecol 1992: 166: 1482-1485.
24. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002: 359: 108-113.
25. Palefsky JM, Holly EA. Chapter 6: immunosuppression and co-infection with HIV. J Natl Cancer Institute Monogr 2003, 41-46.
26. Holly E, Ralston MR, Darragh TM et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001: 93: 943-949.
27. Goedert JJ, Cote TR, Virgo P et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998: 351: 1833-1839.
28. Palefsky JM, Holly EA, Ralston ML et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J AIDS 2001: 28: 422-428.
29. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998: 12: 1459-1464.
30. Minkoff H, Ahdieh L, Massad LS et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001: 15: 2157-2164.
31. Haga T, Kim S-H, Jensen R et al. Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr 2001: 26: 256-262.
32. Bonnez W, Reichman RC. Papillomaviruses. In: Mandell GL, Bennett JE, and Dolin R, eds. Principles and practice of infectious disease, Vol. 2, 5th edn. Philadelphia: PA Churchill Livingstone 2000: 1630-1644.
33. Ponten J, Adami HO, Bergstrom R et al. Strategies for global control of cervical cancer. Int J Cancer 1995: 60: 1-26.
34. Eddy DM. Screening for cervical cancer. Ann Intern Med 1990: 113: 214-226.
35. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology: sensitivity, specificity and predictive values. Acta Cytol 1991: 35: 8-14.
36. Kulasingam SL, Hughes JP, Kiviat NB et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002: 288: 1749-1757.
37. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000: 9: 945-951.
38. Wright TC Jr. Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002: 287: 2120-2129.
39. Goldie SJ, Kuntz KM, Weinstein MC et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999: 281: 1822-1829.
40. Goldie SJ, Kuntz KM, Weinstein MC et al. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000: 108: 634-641.
41. Palefsky J, Holly E, Hogeboom CJ et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J AIDS 1997: 14: 415.
42. Beutner KR, Reitano MV, Richwald GA, Wiley DJ. External genital warts: report of the American Medical Association Consensus Conference. AMA expert panel on external genital warts. Clin Infect Dis 1998: 27: 796-806.
43. Jablonska S. Traditional therapies for the treatment of condylomata acuminata (genital warts). Australas J Dermatol 1998: 39 (Suppl. 1): S2-S4.
44. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999: 91: 252-258.
45. Roden RB, Ling M, Wu TC. Vaccination to prevent and treat cervical cancer. Hum Pathol 2004: 35: 971-982.
46. Koutsky LA, Ault KA, Wheeler CM et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002: 347: 1645-1651.